Cecilia J Hillard Selected Research

Cecilia J Hillard Research Topics

Disease

12	Inflammation (Inflammations) 08/2022 - 10/2005
11	Pain (Aches) 08/2022 - 10/2011
10	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 12/2013
8	Parkinson Disease (Parkinson's Disease) 12/2021 - 04/2003
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2003
4	Obesity 01/2020 - 12/2009
4	Neuroblastoma 10/2005 - 04/2003
3	Hyperalgesia 01/2022 - 10/2011
3	Cognitive Dysfunction 01/2020 - 03/2005
3	Neuroinflammatory Diseases 05/2018 - 11/2015
3	Shock 01/2018 - 01/2017
3	Nervous System Diseases (Neurological Disorders) 01/2017 - 09/2007
3	Mood Disorders (Mood Disorder) 09/2009 - 08/2008
2	Fatigue 08/2022 - 01/2019
2	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2022 - 01/2021
2	Anxiety Disorders (Anxiety Disorder) 05/2022 - 09/2012
2	Wounds and Injuries (Trauma) 01/2022 - 05/2021
2	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2021 - 01/2021
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2021 - 01/2021
2	Neuralgia (Stump Neuralgia) 01/2021 - 01/2017
2	Substance-Related Disorders (Drug Abuse) 01/2021 - 08/2005
2	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 01/2019
2	Neoplasms (Cancer) 10/2020 - 12/2004
2	Autoimmune Diseases (Autoimmune Disease) 10/2020 - 04/2007
2	Ataxia (Dyssynergia) 01/2017 - 12/2016
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2017 - 12/2016
2	Mental Disorders (Mental Disorder) 11/2016 - 10/2012
2	Amyloid Plaque 11/2015 - 12/2003
2	Cystitis 04/2015 - 10/2011
2	Dyslipidemias (Dyslipidemia) 01/2015 - 12/2009
2	Parkinsonian Disorders (Parkinsonism) 02/2010 - 10/2005
2	Insulin Resistance 12/2009 - 11/2008
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2007 - 10/2005
2	Multiple Sclerosis 04/2007 - 02/2007
1	Leukemia 08/2022
1	Cushing Syndrome 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Stroke (Strokes) 12/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021
1	Bronchiolitis Obliterans Syndrome 01/2021
1	Chronic Pain 01/2021
1	Prolonged Grief Disorder 10/2020
1	Familial cyclic vomiting syndrome 01/2020
1	Confusion (Bewilderment) 01/2019
1	Corneal Injuries 01/2019

Drug/Important Bio-Agent (IBA)

32	EndocannabinoidsIBA 01/2022 - 12/2003
16	CannabinoidsIBA 01/2022 - 12/2003
10	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2018 - 12/2003
8	Cannabinoid Receptors (Cannabinoid Receptor)IBA 11/2021 - 05/2006
6	LipidsIBA 01/2021 - 08/2005
6	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 01/2020 - 12/2004
5	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2018 - 12/2004
5	EnzymesIBA 01/2017 - 04/2003
4	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 01/2018 - 10/2011
4	anandamide (arachidonylethanolamide)IBA 01/2018 - 06/2010
3	CytokinesIBA 08/2022 - 11/2015
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 11/2015
3	CB2 Cannabinoid ReceptorIBA 01/2022 - 10/2005
3	Neuroprotective AgentsIBA 12/2021 - 12/2010
3	CannabidiolIBA 09/2021 - 12/2008
3	LeptinIBA 01/2020 - 01/2015
3	Glutamic Acid (Glutamate)FDA Link 12/2016 - 03/2004
3	Fatty Acids (Saturated Fatty Acids)IBA 10/2011 - 09/2007
3	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 10/2005 - 04/2003
3	NeurotoxinsIBA 10/2005 - 04/2003
2	tocilizumab (atlizumab)FDA Link 08/2022 - 01/2021
2	enhanced green fluorescent proteinIBA 01/2022 - 05/2018
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 12/2013
2	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 03/2004
2	Glucose (Dextrose)FDA LinkGeneric 12/2016 - 12/2009
2	GlucocorticoidsIBA 01/2015 - 12/2013
2	Insulin (Novolin)FDA Link 01/2015 - 12/2009
2	AntioxidantsIBA 12/2010 - 04/2003
2	RotenoneIBA 02/2010 - 10/2005
2	Messenger RNA (mRNA)IBA 02/2010 - 10/2005
2	alpha-SynucleinIBA 02/2010 - 04/2004
2	Oxidants (Oxidizing Agents)IBA 02/2010 - 04/2004
2	Adenosine (Adenocard)FDA LinkGeneric 12/2008 - 05/2006
2	Lipoproteins (Lipoprotein)IBA 09/2007 - 09/2007
2	IronIBA 04/2004 - 04/2003
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 08/2022
1	OrexinsIBA 05/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	3- (1,1- dimethyl- heptyl)- 1- hydroxy- 9- methoxy- benzo(c)chromen- 6- oneIBA 01/2022
1	CB2 receptor agonist LY2828360IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	2- ((2,4- dichlorphenyl)amino)- N- ((tetrahydro- 2H- pyran- 4- yl)methyl)- 4- (trifluoromethyl)- 5- pyrimidinecarboxamideIBA 12/2021
1	Oxidopamine (6 Hydroxydopamine)IBA 12/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2021
1	Dronabinol (THC)FDA LinkGeneric 09/2021
1	Biological ProductsIBA 05/2021
1	InterleukinsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	methylamphotericin B (AME)IBA 01/2020
1	AntiemeticsIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	Naltrexone (ReVia)FDA LinkGeneric 01/2018

Therapy/Procedure

3	Therapeutics 01/2021 - 07/2017
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
1	Hematopoietic Stem Cell Transplantation 01/2021